Finance

Lists
539730:BOM
Fredun Pharmaceuticals Ltd
၁,၄၇၈.၃၅ ₹
+၁.၈၄%
(+၂၆.၇၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539730...
Open
၁,၄၇၃.၆၀ ₹
High
၁,၄၉၈.၀၀ ₹
Low
၁,၄၃၄.၇၅ ₹
Mkt. cap
ဋေ ၂.၄၇ ထ
Avg. vol.
၁.၈၄ သောင်း
Volume
၆.၁၂ ထောင်
P/E ratio
၅၅.၁၄
52-wk high
၁,၆၆၆.၃၅ ₹
52-wk low
၄၅၄.၀၅ ₹
EPS
၂၆.၈၁ ₹
Shares outstanding
၃.၉၉ သန်း
No. of employees
၇၃၆
Open
၁,၄၇၃.၆၀ ₹
High
၁,၄၉၈.၀၀ ₹
Low
၁,၄၃၄.၇၅ ₹
Mkt. cap
ဋေ ၂.၄၇ ထ
Avg. vol.
၁.၈၄ သောင်း
Volume
၆.၁၂ ထောင်
P/E ratio
၅၅.၁၄
52-wk high
၁,၆၆၆.၃၅ ₹
52-wk low
၄၅၄.၀၅ ₹
EPS
၂၆.၈၁ ₹
Shares outstanding
၃.၉၉ သန်း
No. of employees
၇၃၆
News stories
From web sources and news partners
01net
01net
·
ပြီးခဲ့သည့် ၉ မိနစ်
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၃၉ မိနစ်
CRISPR Therapeutics (NASDAQ:CRSP) Director Sells 14,514 Shares of Stock
CNN
CNN
·
ပြီးခဲ့သည့် ၄ နာရီ
Nasdaq sinks more than 2% as investors raise questions about AI debt
About Fredun Pharmaceuticals Ltd
CEO-
Employees၇၃၆
Founded၁၉၈၇
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၁၃
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
၂၂၇.၇၆ ဋေ / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၄၃.၅၉ ဋေ
၁၅၉.၉၃ ဋေ
၂၁၂.၅၅ ဋေ
၂၂၇.၇၆ ဋေ
Cost of goods sold
၁၀၈.၅၂ ဋေ
၁၁၅.၂၈ ဋေ
၁၆၀.၂၃ ဋေ
၁၇၇.၄၅ ဋေ
Cost of revenue
၁၀၈.၅၂ ဋေ
၁၁၅.၂၈ ဋေ
၁၆၀.၂၃ ဋေ
၁၇၇.၄၅ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၈.၃၀ ကုဋေ
၈.၁၅ ကုဋေ
၄၈.၄၂ ကုဋေ
၇.၁၂ ကုဋေ
Operating expense
၁၆.၃၄ ကုဋေ
၂၁.၀၉ ကုဋေ
၂၇.၀၉ ကုဋေ
၂၁.၆၃ ကုဋေ
Total operating expenses
၁၂၄.၈၅ ဋေ
၁၃၆.၃၇ ဋေ
၁၈၇.၃၂ ဋေ
၁၉၉.၀၈ ဋေ
Operating income
၁၈.၇၃ ကုဋေ
၂၃.၅၅ ကုဋေ
၂၅.၂၃ ကုဋေ
၂၈.၆၈ ကုဋေ
Other non operating income
၁.၇၁ ကုဋေ
၉.၉၇ သန်း
-၄.၉၇ ကုဋေ
၄.၉၂ သန်း
EBT including unusual items
၁၂.၇၁ ကုဋေ
၁၄.၀၀ ကုဋေ
၁၁.၂၅ ကုဋေ
၂၀.၅၅ ကုဋေ
EBT excluding unusual items
၁၂.၇၁ ကုဋေ
၁၄.၀၀ ကုဋေ
၁၁.၂၅ ကုဋေ
၂၀.၅၅ ကုဋေ
Income tax expense
၃.၂၇ ကုဋေ
၃.၅၂ ကုဋေ
၅.၃၀ ကုဋေ
၇.၄၂ ကုဋေ
Effective tax rate
၂၅.၇၇%
၂၅.၁၇%
၄၇.၁၄%
၃၆.၁၀%
Other operating expenses
၆.၁၅ ကုဋေ
၁၁.၁၆ ကုဋေ
-၂၄.၄၈ ကုဋေ
၁၀.၉၄ ကုဋေ
Net income
၉.၄၃ ကုဋေ
၁၀.၄၈ ကုဋေ
၅.၉၅ ကုဋေ
၁၃.၁၃ ကုဋေ
Net profit margin
၆.၅၇%
၆.၅၅%
၂.၈၀%
၅.၇၇%
Earnings per share
-
-
-
-
Interest and investment income
-
-
၆.၆၀ သန်း
-
Interest expense
-၇.၇၃ ကုဋေ
-၁၀.၅၅ ကုဋေ
-၁၂.၆၈ ကုဋေ
-၈.၆၂ ကုဋေ
Net interest expenses
-၇.၇၃ ကုဋေ
-၁၀.၅၅ ကုဋေ
-၁၂.၀၂ ကုဋေ
-၈.၆၂ ကုဋေ
Depreciation and amortization charges
၁.၈၉ ကုဋေ
၁.၇၈ ကုဋေ
၃.၁၅ ကုဋေ
၃.၅၇ ကုဋေ
EBITDA
၂၀.၃၉ ကုဋေ
၂၄.၇၈ ကုဋေ
၂၇.၂၈ ကုဋေ
၃၀.၇၂ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ